Flexion Therapeutics

Woburn, United States Founded: 2007 • Age: 19 yrs Listed Acquired By Pacira
Developer of therapies for the treatment of musculoskeletal disorders

About Flexion Therapeutics

Flexion Therapeutics is a Healthcare company based in Woburn (United States) founded in 2007, and was acquired by Pacira in October 2021. Flexion Therapeutics has raised $62 million across 4 funding rounds from investors including Pfizer, Pacira and 5AM Ventures. The company has 692 employees. Its focus areas include Life Sciences, Pain Management, Drugs and Diversified. Its competitors include Formation Bio, Eliem Therapeutics and Zogenix; 3 of its 3 listed competitors have raised funding.

Company details

Developer of therapies for the treatment of musculoskeletal disorders. The company is currently advancing a portfolio of injectable drug candidates that have the potential to provide better and more persistent analgesia compared with existing therapies. Their lead program, FX006, is an intra-articular sustained-release steroid injectable for patients with moderate to severe osteoarthritis (OA) pain. They also have two additional product candidates FX007, a locally administered TrkA receptor antagonist for post-operative pain, and FX005, an intra-articular, sustained-release p38 MAP kinase inhibitor for end-stage OA patients.

Key Metrics
  • Annual Revenue
    $85.55 M (USD)
    17
    as on Dec 31, 2020
  • Net Profit
    -$113.71 M (USD)
    24
    as on Dec 31, 2020
  • EBITDA
    -$93.02 M (USD)
    32
    as on Dec 31, 2020
  • Total Equity Funding
    $62M (USD)

    in 4 rounds

  • Latest Funding Round
    $175M (USD), Post-IPO

    May 2017

  • Investors
    Pfizer

    & 6 more

  • Employee Count
    692
  • Acquired by
    Pacira

    (Oct 2021)

Funding Insights of Flexion Therapeutics

Flexion Therapeutics has successfully raised a total of $62M across 4 strategic funding rounds. The most recent funding activity was a Post-IPO round of $175 million completed in May 2017. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding $62M
  • Total Rounds 4
  • Last Round Post-IPO β€” $175M
  • First Round $42M

    (Oct 2009)

  • Investors Count 6

All 4 funding rounds of Flexion Therapeutics with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
May 2017$175MPost-IPO––
–
Apr 2017$201.3MPost-IPO––
–
Dec 2012$20MSeries B–Novo Holdings
Oct 2009$42MSeries A–Versant Ventures
Valuation history

7 investors in total: 7 institutional.

Investors in Flexion Therapeutics

Flexion Therapeutics has secured backing from 7 investors, including venture fund and institutional investors. Prominent investors backing the company include Pfizer, Pacira and 5AM Ventures.

All
Venture Fund
Institutional
InvestorDescriptionFounded YearDomainLocation
Venture capital fund backed incubator focused on the healthcare startups
5amventures.comSan Francisco, United States
Venture capital firm managing investments in biotechnology and pharmaceuticals since 1999.
versantventures.com
Private equity and venture capital fund focused on the healthcare sector
novoholdings.dkHellerup, Denmark
Venture capital is focused on healthcare by Pfizer's investment arm.
pfizer.com/partnering/areas_of_interest/venture_investmentsNew York, United States
Sofinnova Partners is focused on life sciences and healthcare investments.
sofinnovapartners.comParis, France
Pharmaceutical products for treating multiple diseases are provided.
1849pfizer.comNew York, United States
Injectable non-opioid products for post-surgical pain control are developed.
2006pacira.comParsippany Troy Hills, United States
Premium access

Investor details for Flexion Therapeutics

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

People of Flexion Therapeutics

283 people are tracked at Flexion Therapeutics (147 in leadership, 10 in board & advisors, 126 in team); the tracked headcount is 692.

NameRoleGroup
Tyler Jones
Area Director Of Sales-westLeadership
Bryan Darge
Associate Director Market Access & ReimbursementLeadership
Sara Ghazaii Marino
Executive Director, Head Of Corporate CommunicationsLeadership
Leanna B.
Director, Sales OperationsLeadership
Susan Mesco
Vice President Investor RelationsLeadership
Rosanne Atencio
Executive DirectorLeadership
Steven Savage
Associate Director, Corporate AccountingLeadership
Jonathan Slonin
Chief Medical OfficerLeadership
Maksim N.
Executive Director Of Corporate And Business DevelopmentLeadership
Peter Hefti Cma, Cpa
Director - Science Center Campus ControllerLeadership
Jeremy Grubb
Regional Business DirectorLeadership
Jillian Mangiro Phr
Senior Director, HR Business PartnerLeadership
Alex Celius
Director, ComplianceLeadership
Ebenezer Egyepong
Associate DirectorLeadership
Scott Daul
Senior Director Of Market Access - ReimbursementLeadership
David Cochran
Director IT Project ManagementLeadership
Chad Brightwell
Regional Sales DirectorLeadership
Jared Ham Pharmd, Bcps, Bcccp
Medical Science Liaison, DirectorLeadership
Stan Dysart M.D., Mba, Faaos
Vice President Medical Affairs, OrthopaedicsLeadership
William L. Lanzer
Sr Director Medical Affairs - Orthopedic Specialty GroupLeadership

263 more people are available in the full profile.

Premium access

Complete people profiles for Flexion Therapeutics

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Timeline of Flexion Therapeutics

5 dated milestones of Flexion Therapeutics across 14 years, from founding to its latest funding, stage changes and deals.

  1. Founded Flexion Therapeutics is founded.
  2. Funding First funding round of $42.0M.
  3. IPO Lists on the stock exchange (IPO).
  4. Funding Latest funding round, Post-IPO, of $175.0M.
  5. Exit Acquired by Pacira.

Competitors of Flexion Therapeutics

Flexion Therapeutics has 3 listed competitors in our database, 3 of them funded. They include Formation Bio, Eliem Therapeutics and Zogenix.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
formation.bio2016New York, United States$608.25M
AI-powered drug discovery platform for various diseases
eliemtx.com2018Boston, United States$171.3M30
Develops antibody-based treatments for autoimmune and inflammatory disorders.
zogenix.com2006Emeryville, United States$149.06M159
Drug delivery systems for CNS disorders and pain are developed.
Premium access

Detailed competitors of Flexion Therapeutics

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Web traffic of Flexion Therapeutics

Websites that share an audience with Flexion Therapeutics (flexiontherapeutics.com).

Similar websites

Websites whose visitors overlap most with Flexion Therapeutics. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
concertpharma.com
100%
View details
elevenbio.com
elevenbio.com
91%
–
auspexpharma.com
83%
View details
alderbio.com
82%
View details
arenapharm.com
82%
View details
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
Premium access

All 13 similar websites and full traffic analytics for Flexion Therapeutics

The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.

  • 13 similar websites
  • Audience overlap
  • Engagement analytics
  • Traffic by brand

Verified entity values are shown only after access is granted.

Top companies in Orthopedics

3 companies that operate in the same segment as Flexion Therapeutics (Orthopedics) in United States, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Provider of high-frequency spinal cord stimulation implants
2006Menlo Park, California, United StatesUSD 154.1 MUSD 353.08 M1,215
Antibody-siRNA complexes are developed for cancer treatment.
2012San Diego, California, United StatesUSD 142.54 MUSD 10.9 M391
Smart surgical devices for spinal surgery are developed.
1997San Diego, California, United StatesUSD 54.1 M
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Flexion Therapeutics

Premium access

Complete news archive for Flexion Therapeutics

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Flexion Therapeutics

Flexion Therapeutics was founded in 2007 and raised its 1st funding round 2 years after it was founded.

Flexion Therapeutics is headquartered in Woburn, United States. It is registered at Woburn, Massachusetts, United States.

Flexion Therapeutics is a funded company, having raised a total of $62M across 4 funding rounds to date. The company's 1st funding round was a Series A of $42M, raised on Oct 2009.

Flexion Therapeutics has 692 employees.

Annual revenue of Flexion Therapeutics is $85.55M as on Dec 31, 2020.

Developer of therapies for the treatment of musculoskeletal disorders. The company is currently advancing a portfolio of injectable drug candidates that have the potential to provide better and more persistent analgesia compared with existing therapies. Their lead program, FX006, is an intra-articular sustained-release steroid injectable for patients with moderate to severe osteoarthritis (OA) pain. They also have two additional product candidates FX007, a locally administered TrkA receptor antagonist for post-operative pain, and FX005, an intra-articular, sustained-release p38 MAP kinase inhibitor for end-stage OA patients.

Flexion Therapeutics's top competitors include Formation Bio, Zogenix and Eliem Therapeutics.

Flexion Therapeutics has 7 investors. Key investors include Pfizer, Pacira, 5AM Ventures, Versant Ventures, and Novo Holdings.

Yes. Flexion Therapeutics was acquired by Pacira in October 2021.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available